GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (WBO:NZYM) » Definitions » Stock Based Compensation

Novonesis (Novozymes) B (WBO:NZYM) Stock Based Compensation : €0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Novonesis (Novozymes) B Stock Based Compensation?

Novonesis (Novozymes) B's Stock Based Compensation for the three months ended in Jun. 2024 was €0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2024 was €0 Mil.

Novonesis (Novozymes) B Stock Based Compensation Historical Data

The historical data trend for Novonesis (Novozymes) B's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Stock Based Compensation Chart

Novonesis (Novozymes) B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.16 7.26 10.49 17.04 20.28

Novonesis (Novozymes) B Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novonesis (Novozymes) B Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Novonesis (Novozymes) B Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (WBO:NZYM) » Definitions » Stock Based Compensation
Comparable Companies
OCSE:SPG OCSE:FLUG B OCSE:HOVE LIN XPAR:AI SHW ECL APD XSWX:SIKA ISX:TPIA XSWX:GIVN SHSE:600309 BOM:500820 DD XAMS:DSFIR PPG LYB IFF NSE:PIDILITIND ADX:BOROUGE
Traded in Other Exchanges
NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM2:Germany
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Website
https://www.novozymes.com
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines